http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 01 Oct 2026 16:14:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Starling+Oncology+Leadership+Highlights+Recent+and+Upcoming+Industry+Conference+Participation/27136088.html <p>CERRITOS, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Starling Oncology™, Inc. (NASDAQ: STLN), (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today highlighted its leadership team’s active season of industry engagement, recapping recent conference participation and previewing upcoming appearances at major industry events.</p> <p>These presentations reflect Starling Oncology’s role in advancing the science and practice of value-based community oncology. Across these forums, the Company’s physician leaders are sharing clinical insights drawn from its proprietary and innovative Starling Nexus™ utilization management platform and its community-based care model, including approaches to http://www.streetinsider.com/Press+Releases/Starling+Oncology+Leadership+Highlights+Recent+and+Upcoming+Industry+Conference+Participation/27136088.html Thu, 01 Oct 2026 16:14:00 -0400 STLN TOIIW http://www.streetinsider.com/Globe+Newswire/Starling+Oncology+Leadership+Highlights+Recent+and+Upcoming+Industry+Conference+Participation/27136088.html <p>CERRITOS, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Starling Oncology™, Inc. (NASDAQ: STLN), (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today highlighted its leadership team’s active season of industry engagement, recapping recent conference participation and previewing upcoming appearances at major industry events.</p> <p>These presentations reflect Starling Oncology’s role in advancing the science and practice of value-based community oncology. Across these forums, the Company’s physician leaders are sharing clinical insights drawn from its proprietary and innovative Starling Nexus™ utilization management platform and its community-based care model, including approaches to http://www.streetinsider.com/Globe+Newswire/Starling+Oncology+Leadership+Highlights+Recent+and+Upcoming+Industry+Conference+Participation/27136088.html Thu, 01 Oct 2026 16:14:00 -0400 STLN TOIIW http://www.streetinsider.com/Press+Releases/Starling+Oncology+Leadership+Highlights+Recent+and+Upcoming+Industry+Conference+Participation/27136088.html <p>CERRITOS, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Starling Oncology™, Inc. (NASDAQ: STLN), (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today highlighted its leadership team’s active season of industry engagement, recapping recent conference participation and previewing upcoming appearances at major industry events.</p> <p>These presentations reflect Starling Oncology’s role in advancing the science and practice of value-based community oncology. Across these forums, the Company’s physician leaders are sharing clinical insights drawn from its proprietary and innovative Starling Nexus™ utilization management platform and its community-based care model, including approaches to http://www.streetinsider.com/Press+Releases/Starling+Oncology+Leadership+Highlights+Recent+and+Upcoming+Industry+Conference+Participation/27136088.html Thu, 01 Oct 2026 16:14:00 -0400 STLN TOIIW http://www.streetinsider.com/Globe+Newswire/Starling+Oncology+Leadership+Highlights+Recent+and+Upcoming+Industry+Conference+Participation/27136088.html <p>CERRITOS, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Starling Oncology™, Inc. (NASDAQ: STLN), (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today highlighted its leadership team’s active season of industry engagement, recapping recent conference participation and previewing upcoming appearances at major industry events.</p> <p>These presentations reflect Starling Oncology’s role in advancing the science and practice of value-based community oncology. Across these forums, the Company’s physician leaders are sharing clinical insights drawn from its proprietary and innovative Starling Nexus™ utilization management platform and its community-based care model, including approaches to http://www.streetinsider.com/Globe+Newswire/Starling+Oncology+Leadership+Highlights+Recent+and+Upcoming+Industry+Conference+Participation/27136088.html Thu, 01 Oct 2026 16:14:00 -0400 STLN TOIIW http://www.streetinsider.com/Press+Releases/Starling+Oncology+Reports+Second+Quarter+2026+Financial+Results+and+Updates+Full-Year+2026+Guidance/26883941.html <p align="justify">CERRITOS, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Starling Oncology, Inc. (NASDAQ: STLN) (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its quarter ended June 30, 2026 and updated it&apos;s full-year 2026 guidance.</p> <p align="justify"><strong>Recent Operational Highlights</strong></p> <ul type="disc"><li style="text-align:left;">Specialty Pharmacy had record Part D fills driving Specialty Pharmacy revenue up 58% in the quarter as compared to prior year same quarter, driven by continued strength in prescription fill volumes as we bring new capitated lives onto the platform, along with the http://www.streetinsider.com/Press+Releases/Starling+Oncology+Reports+Second+Quarter+2026+Financial+Results+and+Updates+Full-Year+2026+Guidance/26883941.html Thu, 06 Aug 2026 16:14:00 -0400 O.21802973 STLN TOI TOIIW http://www.streetinsider.com/Globe+Newswire/Starling+Oncology+Reports+Second+Quarter+2026+Financial+Results+and+Updates+Full-Year+2026+Guidance/26883941.html <p align="justify">CERRITOS, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Starling Oncology, Inc. (NASDAQ: STLN) (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its quarter ended June 30, 2026 and updated it&apos;s full-year 2026 guidance.</p> <p align="justify"><strong>Recent Operational Highlights</strong></p> <ul type="disc"><li style="text-align:left;">Specialty Pharmacy had record Part D fills driving Specialty Pharmacy revenue up 58% in the quarter as compared to prior year same quarter, driven by continued strength in prescription fill volumes as we bring new capitated lives onto the platform, along with the http://www.streetinsider.com/Globe+Newswire/Starling+Oncology+Reports+Second+Quarter+2026+Financial+Results+and+Updates+Full-Year+2026+Guidance/26883941.html Thu, 06 Aug 2026 16:14:00 -0400 O.21802973 STLN TOI TOIIW http://www.streetinsider.com/Press+Releases/Starling+Oncology+Reports+Second+Quarter+2026+Financial+Results+and+Updates+Full-Year+2026+Guidance/26883941.html <p align="justify">CERRITOS, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Starling Oncology, Inc. (NASDAQ: STLN) (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its quarter ended June 30, 2026 and updated it&apos;s full-year 2026 guidance.</p> <p align="justify"><strong>Recent Operational Highlights</strong></p> <ul type="disc"><li style="text-align:left;">Specialty Pharmacy had record Part D fills driving Specialty Pharmacy revenue up 58% in the quarter as compared to prior year same quarter, driven by continued strength in prescription fill volumes as we bring new capitated lives onto the platform, along with the http://www.streetinsider.com/Press+Releases/Starling+Oncology+Reports+Second+Quarter+2026+Financial+Results+and+Updates+Full-Year+2026+Guidance/26883941.html Thu, 06 Aug 2026 16:14:00 -0400 O.21802973 STLN TOI TOIIW http://www.streetinsider.com/Globe+Newswire/Starling+Oncology+Reports+Second+Quarter+2026+Financial+Results+and+Updates+Full-Year+2026+Guidance/26883941.html <p align="justify">CERRITOS, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Starling Oncology, Inc. (NASDAQ: STLN) (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its quarter ended June 30, 2026 and updated it&apos;s full-year 2026 guidance.</p> <p align="justify"><strong>Recent Operational Highlights</strong></p> <ul type="disc"><li style="text-align:left;">Specialty Pharmacy had record Part D fills driving Specialty Pharmacy revenue up 58% in the quarter as compared to prior year same quarter, driven by continued strength in prescription fill volumes as we bring new capitated lives onto the platform, along with the http://www.streetinsider.com/Globe+Newswire/Starling+Oncology+Reports+Second+Quarter+2026+Financial+Results+and+Updates+Full-Year+2026+Guidance/26883941.html Thu, 06 Aug 2026 16:14:00 -0400 O.21802973 STLN TOI TOIIW http://www.streetinsider.com/Press+Releases/Starling+Oncology+Reports+Second+Quarter+2026+Financial+Results+and+Updates+Full-Year+2026+Guidance/26883941.html <p align="justify">CERRITOS, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Starling Oncology, Inc. (NASDAQ: STLN) (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its quarter ended June 30, 2026 and updated it&apos;s full-year 2026 guidance.</p> <p align="justify"><strong>Recent Operational Highlights</strong></p> <ul type="disc"><li style="text-align:left;">Specialty Pharmacy had record Part D fills driving Specialty Pharmacy revenue up 58% in the quarter as compared to prior year same quarter, driven by continued strength in prescription fill volumes as we bring new capitated lives onto the platform, along with the http://www.streetinsider.com/Press+Releases/Starling+Oncology+Reports+Second+Quarter+2026+Financial+Results+and+Updates+Full-Year+2026+Guidance/26883941.html Thu, 06 Aug 2026 16:14:00 -0400 O.21802973 STLN TOI TOIIW http://www.streetinsider.com/Globe+Newswire/Starling+Oncology+Reports+Second+Quarter+2026+Financial+Results+and+Updates+Full-Year+2026+Guidance/26883941.html <p align="justify">CERRITOS, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Starling Oncology, Inc. (NASDAQ: STLN) (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its quarter ended June 30, 2026 and updated it&apos;s full-year 2026 guidance.</p> <p align="justify"><strong>Recent Operational Highlights</strong></p> <ul type="disc"><li style="text-align:left;">Specialty Pharmacy had record Part D fills driving Specialty Pharmacy revenue up 58% in the quarter as compared to prior year same quarter, driven by continued strength in prescription fill volumes as we bring new capitated lives onto the platform, along with the http://www.streetinsider.com/Globe+Newswire/Starling+Oncology+Reports+Second+Quarter+2026+Financial+Results+and+Updates+Full-Year+2026+Guidance/26883941.html Thu, 06 Aug 2026 16:14:00 -0400 O.21802973 STLN TOI TOIIW http://www.streetinsider.com/Press+Releases/Starling+Oncology+Reports+Second+Quarter+2026+Financial+Results+and+Updates+Full-Year+2026+Guidance/26883941.html <p align="justify">CERRITOS, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Starling Oncology, Inc. (NASDAQ: STLN) (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its quarter ended June 30, 2026 and updated it&apos;s full-year 2026 guidance.</p> <p align="justify"><strong>Recent Operational Highlights</strong></p> <ul type="disc"><li style="text-align:left;">Specialty Pharmacy had record Part D fills driving Specialty Pharmacy revenue up 58% in the quarter as compared to prior year same quarter, driven by continued strength in prescription fill volumes as we bring new capitated lives onto the platform, along with the http://www.streetinsider.com/Press+Releases/Starling+Oncology+Reports+Second+Quarter+2026+Financial+Results+and+Updates+Full-Year+2026+Guidance/26883941.html Thu, 06 Aug 2026 16:14:00 -0400 O.21802973 STLN TOI TOIIW http://www.streetinsider.com/Globe+Newswire/Starling+Oncology+Reports+Second+Quarter+2026+Financial+Results+and+Updates+Full-Year+2026+Guidance/26883941.html <p align="justify">CERRITOS, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Starling Oncology, Inc. (NASDAQ: STLN) (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its quarter ended June 30, 2026 and updated it&apos;s full-year 2026 guidance.</p> <p align="justify"><strong>Recent Operational Highlights</strong></p> <ul type="disc"><li style="text-align:left;">Specialty Pharmacy had record Part D fills driving Specialty Pharmacy revenue up 58% in the quarter as compared to prior year same quarter, driven by continued strength in prescription fill volumes as we bring new capitated lives onto the platform, along with the http://www.streetinsider.com/Globe+Newswire/Starling+Oncology+Reports+Second+Quarter+2026+Financial+Results+and+Updates+Full-Year+2026+Guidance/26883941.html Thu, 06 Aug 2026 16:14:00 -0400 O.21802973 STLN TOI TOIIW http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+to+Participate+in+B.+Riley+Securities+Institutional+Investor+Conference/26482733.html <p>CERRITOS, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in the B. Riley Securities Institutional Investor Conference, being held in Marina Del Rey, CA on Thursday, May 21, 2026, including a fireside chat from 9:00–9:40 a.m. PT.</p> <p>A webcast link of the presentation will be accessible through the Investor Relations section of the Company’s website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=P3zSJKwTo11UGIzhkx-EwodF6U9ehiv1rsxcWTUaRM1dwW2d18W2kJdVtRiNe-u5Lf45ml-ZjL-mn0OUH1mv4z0VpIFQaeQp_jUQymFsaofBdy6tDrMjueb3QAaHGQAyAwf1YPU3Epr7b6B5jrw5xT-WvPVo_TM8q9eaQJcmbH0=" rel="nofollow" target="_blank"><strong>https://investors.theoncologyinstitute.com/</strong></a>.</p> <p>____________________________</p> http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+to+Participate+in+B.+Riley+Securities+Institutional+Investor+Conference/26482733.html Wed, 13 May 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+to+Participate+in+B.+Riley+Securities+Institutional+Investor+Conference/26482733.html <p>CERRITOS, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in the B. Riley Securities Institutional Investor Conference, being held in Marina Del Rey, CA on Thursday, May 21, 2026, including a fireside chat from 9:00–9:40 a.m. PT.</p> <p>A webcast link of the presentation will be accessible through the Investor Relations section of the Company’s website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=P3zSJKwTo11UGIzhkx-EwodF6U9ehiv1rsxcWTUaRM1dwW2d18W2kJdVtRiNe-u5Lf45ml-ZjL-mn0OUH1mv4z0VpIFQaeQp_jUQymFsaofBdy6tDrMjueb3QAaHGQAyAwf1YPU3Epr7b6B5jrw5xT-WvPVo_TM8q9eaQJcmbH0=" rel="nofollow" target="_blank"><strong>https://investors.theoncologyinstitute.com/</strong></a>.</p> <p>____________________________</p> http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+to+Participate+in+B.+Riley+Securities+Institutional+Investor+Conference/26482733.html Wed, 13 May 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+to+Participate+in+B.+Riley+Securities+Institutional+Investor+Conference/26482733.html <p>CERRITOS, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in the B. Riley Securities Institutional Investor Conference, being held in Marina Del Rey, CA on Thursday, May 21, 2026, including a fireside chat from 9:00–9:40 a.m. PT.</p> <p>A webcast link of the presentation will be accessible through the Investor Relations section of the Company’s website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=P3zSJKwTo11UGIzhkx-EwodF6U9ehiv1rsxcWTUaRM1dwW2d18W2kJdVtRiNe-u5Lf45ml-ZjL-mn0OUH1mv4z0VpIFQaeQp_jUQymFsaofBdy6tDrMjueb3QAaHGQAyAwf1YPU3Epr7b6B5jrw5xT-WvPVo_TM8q9eaQJcmbH0=" rel="nofollow" target="_blank"><strong>https://investors.theoncologyinstitute.com/</strong></a>.</p> <p>____________________________</p> http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+to+Participate+in+B.+Riley+Securities+Institutional+Investor+Conference/26482733.html Wed, 13 May 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+to+Participate+in+B.+Riley+Securities+Institutional+Investor+Conference/26482733.html <p>CERRITOS, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in the B. Riley Securities Institutional Investor Conference, being held in Marina Del Rey, CA on Thursday, May 21, 2026, including a fireside chat from 9:00–9:40 a.m. PT.</p> <p>A webcast link of the presentation will be accessible through the Investor Relations section of the Company’s website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=P3zSJKwTo11UGIzhkx-EwodF6U9ehiv1rsxcWTUaRM1dwW2d18W2kJdVtRiNe-u5Lf45ml-ZjL-mn0OUH1mv4z0VpIFQaeQp_jUQymFsaofBdy6tDrMjueb3QAaHGQAyAwf1YPU3Epr7b6B5jrw5xT-WvPVo_TM8q9eaQJcmbH0=" rel="nofollow" target="_blank"><strong>https://investors.theoncologyinstitute.com/</strong></a>.</p> <p>____________________________</p> http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+to+Participate+in+B.+Riley+Securities+Institutional+Investor+Conference/26482733.html Wed, 13 May 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+to+Participate+in+B.+Riley+Securities+Institutional+Investor+Conference/26482733.html <p>CERRITOS, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in the B. Riley Securities Institutional Investor Conference, being held in Marina Del Rey, CA on Thursday, May 21, 2026, including a fireside chat from 9:00–9:40 a.m. PT.</p> <p>A webcast link of the presentation will be accessible through the Investor Relations section of the Company’s website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=P3zSJKwTo11UGIzhkx-EwodF6U9ehiv1rsxcWTUaRM1dwW2d18W2kJdVtRiNe-u5Lf45ml-ZjL-mn0OUH1mv4z0VpIFQaeQp_jUQymFsaofBdy6tDrMjueb3QAaHGQAyAwf1YPU3Epr7b6B5jrw5xT-WvPVo_TM8q9eaQJcmbH0=" rel="nofollow" target="_blank"><strong>https://investors.theoncologyinstitute.com/</strong></a>.</p> <p>____________________________</p> http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+to+Participate+in+B.+Riley+Securities+Institutional+Investor+Conference/26482733.html Wed, 13 May 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+to+Participate+in+B.+Riley+Securities+Institutional+Investor+Conference/26482733.html <p>CERRITOS, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in the B. Riley Securities Institutional Investor Conference, being held in Marina Del Rey, CA on Thursday, May 21, 2026, including a fireside chat from 9:00–9:40 a.m. PT.</p> <p>A webcast link of the presentation will be accessible through the Investor Relations section of the Company’s website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=P3zSJKwTo11UGIzhkx-EwodF6U9ehiv1rsxcWTUaRM1dwW2d18W2kJdVtRiNe-u5Lf45ml-ZjL-mn0OUH1mv4z0VpIFQaeQp_jUQymFsaofBdy6tDrMjueb3QAaHGQAyAwf1YPU3Epr7b6B5jrw5xT-WvPVo_TM8q9eaQJcmbH0=" rel="nofollow" target="_blank"><strong>https://investors.theoncologyinstitute.com/</strong></a>.</p> <p>____________________________</p> http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+to+Participate+in+B.+Riley+Securities+Institutional+Investor+Conference/26482733.html Wed, 13 May 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+Announces+First+Quarter+2026+Earnings+Release+Date+and+Conference+Call/26370693.html <p>CERRITOS, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) a pioneer in value-based community oncology care, today announced that the company will release its first quarter 2026 financial results on Thursday, May 7, 2026, to be followed by a conference call the same day at 5:30 p.m. (Eastern Time).</p> <p>The conference call can be accessed live over the phone by dialing 1-800-225-9448 or for international callers, 1-203-518-9708. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+Announces+First+Quarter+2026+Earnings+Release+Date+and+Conference+Call/26370693.html Mon, 27 Apr 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+Announces+First+Quarter+2026+Earnings+Release+Date+and+Conference+Call/26370693.html <p>CERRITOS, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) a pioneer in value-based community oncology care, today announced that the company will release its first quarter 2026 financial results on Thursday, May 7, 2026, to be followed by a conference call the same day at 5:30 p.m. (Eastern Time).</p> <p>The conference call can be accessed live over the phone by dialing 1-800-225-9448 or for international callers, 1-203-518-9708. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+Announces+First+Quarter+2026+Earnings+Release+Date+and+Conference+Call/26370693.html Mon, 27 Apr 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+Announces+First+Quarter+2026+Earnings+Release+Date+and+Conference+Call/26370693.html <p>CERRITOS, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) a pioneer in value-based community oncology care, today announced that the company will release its first quarter 2026 financial results on Thursday, May 7, 2026, to be followed by a conference call the same day at 5:30 p.m. (Eastern Time).</p> <p>The conference call can be accessed live over the phone by dialing 1-800-225-9448 or for international callers, 1-203-518-9708. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+Announces+First+Quarter+2026+Earnings+Release+Date+and+Conference+Call/26370693.html Mon, 27 Apr 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+Announces+First+Quarter+2026+Earnings+Release+Date+and+Conference+Call/26370693.html <p>CERRITOS, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) a pioneer in value-based community oncology care, today announced that the company will release its first quarter 2026 financial results on Thursday, May 7, 2026, to be followed by a conference call the same day at 5:30 p.m. (Eastern Time).</p> <p>The conference call can be accessed live over the phone by dialing 1-800-225-9448 or for international callers, 1-203-518-9708. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+Announces+First+Quarter+2026+Earnings+Release+Date+and+Conference+Call/26370693.html Mon, 27 Apr 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+Announces+First+Quarter+2026+Earnings+Release+Date+and+Conference+Call/26370693.html <p>CERRITOS, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) a pioneer in value-based community oncology care, today announced that the company will release its first quarter 2026 financial results on Thursday, May 7, 2026, to be followed by a conference call the same day at 5:30 p.m. (Eastern Time).</p> <p>The conference call can be accessed live over the phone by dialing 1-800-225-9448 or for international callers, 1-203-518-9708. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+Announces+First+Quarter+2026+Earnings+Release+Date+and+Conference+Call/26370693.html Mon, 27 Apr 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+Announces+First+Quarter+2026+Earnings+Release+Date+and+Conference+Call/26370693.html <p>CERRITOS, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) a pioneer in value-based community oncology care, today announced that the company will release its first quarter 2026 financial results on Thursday, May 7, 2026, to be followed by a conference call the same day at 5:30 p.m. (Eastern Time).</p> <p>The conference call can be accessed live over the phone by dialing 1-800-225-9448 or for international callers, 1-203-518-9708. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+Announces+First+Quarter+2026+Earnings+Release+Date+and+Conference+Call/26370693.html Mon, 27 Apr 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Corporate+News/Oncology+Institute+generates+%241.8+million+in+Medicare+savings/26303796.html <p>The Oncology Institute of Hope and Innovation (NASDAQ: TOI) achieved $1.8 million in Medicare savings during Performance Period 3 of the Centers for Medicare & Medicaid Services' Enhancing Oncology Model through its California professional corporation, according to a company statement.</p><p>The savings equated to more than $6,400 per patient episode, representing an increase from Performance Period 2, when the company generated $1.1 million in savings, or more than $3,500 per episode.</p><p>For the second consecutive performance period, TOI earned the maximum score on avoidable emergency department visits and hospital admissions. The company attributed results to its High-Value Cancer Care program, which includes http://www.streetinsider.com/Corporate+News/Oncology+Institute+generates+%241.8+million+in+Medicare+savings/26303796.html Mon, 13 Apr 2026 09:02:10 -0400 TOI TOIIW